Thoughts On Going Public During The Pandemic And The "Muted" Celebration

Source: Life Science Leader

In this executive virtual roundtable (EVR) segment, Marcio Souza, CEO of Praxis Precision Medicines, a clinical stage biopharma, kicks off the conversation sharing his thought on the “muted” celebration from IPOing during the pandemic. Providing additional perspectives are Tom Frohlich (CBO, Chinook Therapeutics), and David Perry (cofounder and chairman of Better Therapeutics).